Expanded access programmes: Patient interests versus clinical trial integrity Journal Article


Authors: Lorigan, P.; Ascierto, P. A.; Dummer, R.; Eggermont, A. M.; Flaherty, K. T.; Garbe, C.; Gogas, H.; Hauschild, A.; Kefford, R. F.; Kirkwood, J. M.; Larkin, J.; Long, G. V.; Maio, M.; McArthur, G. A.; Ribas, A.; Robert, C.; Schadendorf, D.; Sondak, V. K.; Wolchok, J. D.; Hudson, A. M.
Article Title: Expanded access programmes: Patient interests versus clinical trial integrity
Keywords: survival; ipilimumab; tremelimumab; advanced melanoma; nivolumab
Journal Title: Lancet Oncology
Volume: 16
Issue: 1
ISSN: 1470-2045
Publisher: Elsevier Science, Inc.  
Date Published: 2015-01-01
Start Page: 15
End Page: 17
Language: English
ACCESSION: WOS:000346912800038
PROVIDER: wos
PUBMED: 25638540
DOI: 10.1016/S1470-2045(14)71161-1
Notes: Editorial Material -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok